Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
3251
QXO Inc
QXO
$16.1B
| $99K | ﹤0.01% |
3,783
+395
| +12% | +$11.1K |
|
|
BVC
3252
BitVentures Limited Ordinary Shares
BVC
$2.21B
| $99K | ﹤0.01% |
13,800
+200
| +1% | +$1.44K |
|
|
CLVR
3253
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $98K | ﹤0.01% |
28,489
+4,901
| +21% | +$26.5K |
|
3254
Werewolf Therapeutics
HOWL
$18.8M
| $97K | ﹤0.01% |
45,200
+2,300
| +5% | +$6.34K |
|
3255
Allogene Therapeutics
ALLO
$683M
| $96K | ﹤0.01% |
30,282
-221,618
| -88% | -$971K |
|
3256
ASP Isotopes
ASPI
$539M
| $96K | ﹤0.01% |
100,879
-378,121
| -79% | -$390K |
|
3257
8x8 Inc
EGHT
$290M
| $96K | ﹤0.01% |
38,030
-285,758
| -88% | -$1.02M |
|
3258
Achieve Life Sciences
ACHV
$744M
| $95K | ﹤0.01% |
22,100
-17,500
| -44% | -$88.2K |
|
3259
Laird Superfood
LSF
$48.2M
| $95K | ﹤0.01% |
92,200
+2,100
| +2% | +$2.26K |
|
3260
Pluri
PLUR
$17.5M
| $95K | ﹤0.01% |
19,738
+6,588
| +50% | +$36.6K |
|
|
ZENV
3261
DELISTED
Zenvia
ZENV
| $95K | ﹤0.01% |
90,200
+41,000
| +83% | +$36.9K |
|
3262
Fortress Biotech
FBIO
$91.4M
| $94K | ﹤0.01% |
21,575
+6,347
| +42% | +$43.5K |
|
|
ONCT
3263
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $94K | ﹤0.01% |
15,665
+1,315
| +9% | +$9.26K |
|
3264
a.k.a. Brands
AKA
$119M
| $93K | ﹤0.01% |
17,875
-19,125
| -52% | -$108K |
|
3265
Enlivex Ltd
ENLV
$28.4M
| $93K | ﹤0.01% |
3,926
+147
| +4% | +$5.09K |
|
|
VBNK
3266
VersaBank
VBNK
$628M
| $93K | ﹤0.01% |
+11,900
| New | +$96.4K |
|
|
RVLP
3267
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $93K | ﹤0.01% |
1,079,515
+384,600
| +55% | +$111K |
|
|
UBX
3268
DELISTED
Unity Biotechnology
UBX
| $92K | ﹤0.01% |
38,371
-4,100
| -10% | -$10.9K |
|
|
CBD
3269
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $92K | ﹤0.01% |
137,900
-15,200
| -10% | -$45.4K |
|
3270
Dominari Holdings
DOMH
$70.3M
| $91K | ﹤0.01% |
39,326
+2,000
| +5% | +$5.66K |
|
3271
Mustang Bio
MBIO
$4.59M
| $91K | ﹤0.01% |
884
-4
| -0.5% | -$776 |
|
|
ZFOX
3272
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $90K | ﹤0.01% |
101,970
-24,430
| -19% | -$26.1K |
|
|
PHX
3273
DELISTED
PHX Minerals
PHX
| $89K | ﹤0.01% |
24,392
-85,640
| -78% | -$287K |
|
|
VSTA
3274
DELISTED
Vasta Platform
VSTA
| $89K | ﹤0.01% |
21,500
+1,200
| +6% | +$4.39K |
|
|
BCEL
3275
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $89K | ﹤0.01% |
341,924
+26,300
| +8% | +$16.6K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.